Latest filing published 21 Jan 2022 for BIOGEN INC..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alphonse Galdes: trading record in brief
Alphonse Galdes (senior executive) discloses dealings in Biogen Inc. to SEC (Form 4). The record holds 17 filings, for trades running from 12 February 2020 to 19 January 2022.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 21 January 2022 came the latest disclosure, a share grant in Biogen Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alphonse Galdes
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 658 shares0Common StockSEC:0001127602-22-001864:0
1 of 1 declaration
